Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, January 12, 2023
CordenPharma is pleased to announce the signing of a multi-year agreement commencing in 2023 for the contract manufacturing of a large-volume peptide at its CordenPharma Colorado facility.
read more
Wednesday, January 18, 2023
Charles River Laboratories International, Inc and Rznomics Inc., a South Korea-based biopharmaceutical company specialized in the development of RNA-based gene therapeutics, announced a viral vector contract development and manufacturing organization...
read more
Tuesday, January 24, 2023
AGC Biologics, a global biopharmaceutical contract development and manufacturing organization (CDMO), announced a new commercial manufacturing project at its Seattle protein biologics manufacturing site.
read more
Thursday, February 23, 2023
AllCells®, a Discovery Life Sciences™ company announced the expansion of its apheresis network with the addition of two new centers in Houston, Texas, and Huntsville, Alabama. These new centers complement AllCells' existing presence in two major U.S....
read more
Tuesday, February 28, 2023
Absci Corporation, a generative AI drug creation company, announced its expansion into the European pharmaceutical market with the opening of its Innovation Center, located in Zug, Switzerland.
read more
Northwest Biotherapeutics and Advent BioServices, a leading contract development and manufacturing organization (CDMO) based in the UK, jointly announce that a MIA license has been approved and issued by the Medicines and Healthcare Products ...
read more
Wednesday, September 20, 2023
Future Fields, a biotechnology company that has built the world’s first synthetic biology system to use fruit flies for recombinant protein production, announced the launch of its contract development and manufacturing organization (CDMO) service.
read more
Tuesday, November 14, 2023
ValGenesis, Inc., and Soluciones GXP have partnered to introduce the ValGenesis VLMS product suite alongside Soluciones GXP's immense regulatory expertise across the life sciences sector in Latin America (LATAM).
Uruguay-based Soluciones GXP ...
read more
Tuesday, December 03, 2024
KBI Biopharma, Inc. announced a manufacturing contract with Alanis Therapeutics, Inc. (ATI) for the development of an innovative pre-clinical therapeutic antibody to treat myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) blood cancers...
read more
Thursday, December 19, 2024
Aramis Biotechnologies Inc. and Biodextris Inc. announced a strategic partnership that will leverage the expertise of both companies to ensure efficient downstream manufacturing of clinical materials for Aramis' leading product candidate, a seasonal ...
read more